11 Best NASDAQ Penny Stocks To Buy Right Now

Page 4 of 10

7. OPKO Health, Inc. (NASDAQ:OPK)

Number of Hedge Fund Holders: 22

Stock Price as of December 4: $1.58

OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare company that is involved in the development and commercialization of diagnostics, pharmaceuticals, and healthcare services. The company is focused on cancer, metabolic disorders, infectious diseases, and women’s health. The company’s Pharmaceutical segment sells products such as Rayaldee, which treats secondary hyperparathyroidism in adults with chronic kidney disease, and Somatrogon (branded as NGENLA), a human growth hormone injection developed in partnership with Pfizer.

OPKO Health, Inc. (NASDAQ:OPK) is advancing its oxyntomodulin analog, OPK-88006, which has shown promise in preclinical studies as a potential once-weekly injectable treatment for patients with obesity or metabolic disorders. Additionally, OPKO Health, Inc. (NASDAQ:OPK) is collaborating with Entera Bio to develop an oral version of OPK-88006, which could provide a competitive advantage in the market.

Furthermore, OPKO Health, Inc. (NASDAQ:OPK) is exploring partnerships and business development opportunities to drive growth and unlock value across its segments. The company has established a collaboration with Merck to develop an Epstein-Barr virus multivalent nanoparticle vaccine, which is expected to enter the clinic soon. The company is also eligible to receive milestone payments and royalties on global sales of this vaccine.

Page 4 of 10